BBT Capital Management’s Eli Lilly LLY Stock Holding History

BBT Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,630	Closed	-$513K	–	76
2019 Q2	$513K	Buy	+4,630	New	+$545K	0.6%	55

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBT Capital Management's LLY Position: Q3 2019 in Review

BBT Capital Management sold out of Eli Lilly (LLY) in Q3 2019, closing a stake of 4,630 shares — an estimated $513K sold.

BBT Capital Management first reported a position in LLY in Q2 2019 and held it in 1 quarter. The position peaked at $513K in Q2 2019. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

BBT Capital Management reported no remaining Eli Lilly position as of Q3 2019 after selling out during the quarter.
BBT Capital Management sold 4,630 Eli Lilly shares in Q3 2019, an estimated $513K.
BBT Capital Management first reported a position in Eli Lilly in Q2 2019 and held it in 1 quarter.
BBT Capital Management's Eli Lilly position peaked at $513K in Q2 2019.
1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on BBT Capital Management's 13F filing for Q3 2019.